Morris Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Morris Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$2.53M	Sell	35,648 -458	-1%	-$33.2K	2.39%	21
2022 Q2	$2.78M	Buy	36,106 +707	+2%	+$53.8K	2.48%	19
2022 Q1	$2.58M	Buy	35,399 +8,188	+30%	+$550K	2.01%	24
2021 Q4	$1.7M	Sell	27,211 -9,222	-25%	-$541K	1.25%	26
2021 Q3	$2.16M	Sell	36,433 -1,330	-4%	-$87.6K	1.7%	26
2021 Q2	$2.52M	Sell	37,763 -539	-1%	-$35.1K	1.91%	25
2021 Q1	$2.42M	Sell	38,302 -965	-2%	-$60K	1.96%	23
2020 Q4	$2.44M	Sell	39,267 -4,030	-9%	-$248K	2%	23
2020 Q3	$2.61M	Sell	43,297 -2,774	-6%	-$167K	2.3%	16
2020 Q2	$2.71M	Sell	46,071 -2,804	-6%	-$168K	2.44%	14
2020 Q1	$2.72M	Buy	48,875 +6,908	+16%	+$422K	2.92%	12
2019 Q4	$2.69M	Buy	+41,967	New	+$2.4M	2.26%	18

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Morris Capital Advisors's BMY Position: Q3 2022 in Review

Morris Capital Advisors reduced its Bristol-Myers Squibb (BMY) stake by 1.3% in Q3 2022, selling an estimated $33.2K and leaving 35,648 shares worth $2.53M. The position accounts for 2.39% of the portfolio, ranked #21.

Morris Capital Advisors first reported a position in BMY in Q4 2019 and has held it in 12 quarters since. The position peaked at $2.78M in Q2 2022. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

Morris Capital Advisors held 35,648 shares of Bristol-Myers Squibb worth $2.53M as of Q3 2022.
Morris Capital Advisors sold 458 Bristol-Myers Squibb shares in Q3 2022, an estimated $33.2K.
Bristol-Myers Squibb made up 2.39% of Morris Capital Advisors's portfolio in Q3 2022, its #21 holding.
Morris Capital Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 12 quarters since.
Morris Capital Advisors's Bristol-Myers Squibb position peaked at $2.78M in Q2 2022.
2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Morris Capital Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.